Nancy Gordon

1.5k total citations
36 papers, 1.0k citations indexed

About

Nancy Gordon is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Nancy Gordon has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Immunology. Recurrent topics in Nancy Gordon's work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (7 papers) and Autophagy in Disease and Therapy (7 papers). Nancy Gordon is often cited by papers focused on CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (7 papers) and Autophagy in Disease and Therapy (7 papers). Nancy Gordon collaborates with scholars based in United States, China and Macao. Nancy Gordon's co-authors include Eugenie S. Kleinerman, John Stewart, Lavinia P. Middleton, George H. Perkins, Karin Hahn, Gabriel N. Hortobágyi, Henry M. Kuerer, Mildred Ramírez, Wei Yang and Richard L. Theriault and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

Nancy Gordon

35 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nancy Gordon 536 352 324 244 242 36 1.0k
Kurosh Rahimi 384 0.7× 312 0.9× 298 0.9× 125 0.5× 138 0.6× 46 1.0k
Denis M. Schewe 632 1.2× 653 1.9× 308 1.0× 115 0.5× 316 1.3× 54 1.6k
Markus M. Valter 202 0.4× 338 1.0× 514 1.6× 120 0.5× 131 0.5× 25 1.2k
Haruko Shima 190 0.4× 505 1.4× 207 0.6× 80 0.3× 307 1.3× 34 1.2k
Els Van Nieuwenhuysen 559 1.0× 372 1.1× 180 0.6× 193 0.8× 325 1.3× 99 1.3k
Lisa Giulino‐Roth 479 0.9× 411 1.2× 237 0.7× 68 0.3× 122 0.5× 39 1.1k
Ellen M. Basu 268 0.5× 310 0.9× 140 0.4× 81 0.3× 175 0.7× 58 772
Tomoya Kishimoto 525 1.0× 758 2.2× 381 1.2× 95 0.4× 291 1.2× 34 1.3k
Elvis Terci Valera 275 0.5× 725 2.1× 57 0.2× 144 0.6× 186 0.8× 108 1.4k
Véronique Laithier 370 0.7× 267 0.8× 42 0.1× 139 0.6× 138 0.6× 27 1.1k

Countries citing papers authored by Nancy Gordon

Since Specialization
Citations

This map shows the geographic impact of Nancy Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Gordon more than expected).

Fields of papers citing papers by Nancy Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Gordon. The network helps show where Nancy Gordon may publish in the future.

Co-authorship network of co-authors of Nancy Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Gordon. A scholar is included among the top collaborators of Nancy Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Gordon. Nancy Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Zhiliang, Xueqing Xia, Nancy Gordon, et al.. (2025). Anti-CD137 agonist antibody–independent and clinically feasible preparation of tumor-infiltrating lymphocytes from soft tissue sarcoma and osteosarcoma. Frontiers in Immunology. 16. 1557006–1557006. 3 indexed citations
2.
Cheng, Donghang, Jyothishmathi Swaminathan, Yanwen Yang, et al.. (2024). REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma. Scientific Reports. 14(1). 13596–13596. 2 indexed citations
3.
Truong, Danh D., Jes Chauviere Lee, Najat C. Daw, et al.. (2024). Mapping the Single-Cell Differentiation Landscape of Osteosarcoma. Clinical Cancer Research. 30(15). 3259–3272. 10 indexed citations
4.
Yang, Yanwen, Dmitry Nevozhay, Donghang Cheng, et al.. (2024). Preclinical and Clinical-Scale Magnetic Particle Imaging of Natural Killer Cells: in vitro and ex vivo Demonstration of Cellular Sensitivity, Resolution, and Quantification. Molecular Imaging and Biology. 27(1). 78–88. 1 indexed citations
5.
Truong, Danh D., Salah-Eddine Lamhamedi-Cherradi, R. Porter, et al.. (2023). Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing. BMC Cancer. 23(1). 488–488. 10 indexed citations
6.
Ragoonanan, Dristhi, Izhar Singh Batth, Arun Satelli, et al.. (2021). Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas. Frontiers in Oncology. 11. 760267–760267. 8 indexed citations
7.
Shi, Yin, Han‐Ming Shen, Vidya Gopalakrishnan, & Nancy Gordon. (2021). Epigenetic Regulation of Autophagy Beyond the Cytoplasm: A Review. Frontiers in Cell and Developmental Biology. 9. 675599–675599. 27 indexed citations
8.
Kleinerman, Eugenie S., et al.. (2020). Knock down of Fas-Associated Protein with Death Domain (FADD) Sensitizes Osteosarcoma to TNFα-induced Cell Death. Journal of Cancer. 11(7). 1657–1667. 8 indexed citations
9.
Gordon, Nancy, et al.. (2020). Aerosolized Chemotherapy for Osteosarcoma. Advances in experimental medicine and biology. 1257. 67–73. 6 indexed citations
10.
Kiany, Simin, Douglas J. Harrison, & Nancy Gordon. (2020). The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma. Advances in experimental medicine and biology. 1257. 75–83. 13 indexed citations
11.
Livingston, J. Andrew, Wei‐Lien Wang, Jen-Wei Tsai, et al.. (2018). Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients. Molecular Cancer Therapeutics. 17(6). 1315–1323. 15 indexed citations
12.
Gordon, Nancy, et al.. (2018). Anti‐PD‐1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases. Cancer Medicine. 7(6). 2654–2664. 145 indexed citations
13.
Gordon, Nancy, et al.. (2017). Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy. Advances in experimental medicine and biology. 995. 33–51. 56 indexed citations
14.
Kiany, Simin & Nancy Gordon. (2016). Aerosol Delivery of Interleukin-2 in Combination with Adoptive Transfer of Natural Killer Cells for the Treatment of Lung Metastasis: Methodology and Effect. Methods in molecular biology. 1441. 285–295. 8 indexed citations
15.
16.
Rodriguez, Carlos O., Dennis W. Wilson, Katherine A. Skorupski, et al.. (2009). Aerosol Gemcitabine: Preclinical Safety and In Vivo Antitumor Activity in Osteosarcoma-Bearing Dogs. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(4). 197–206. 35 indexed citations
17.
Gordon, Nancy & Eugenie S. Kleinerman. (2009). The Role of Fas/FasL in the Metastatic Potential of Osteosarcoma and Targeting this Pathway for the Treatment of Osteosarcoma Lung Metastases. Cancer treatment and research. 152. 497–508. 33 indexed citations
18.
Hahn, Karin, Peter H. Johnson, Nancy Gordon, et al.. (2006). Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 107(6). 1219–1226. 244 indexed citations
19.
Gordon, Nancy, Carola A.S. Arndt, Douglas S. Hawkins, et al.. (2005). Fas Expression in Lung Metastasis From Osteosarcoma Patients. Journal of Pediatric Hematology/Oncology. 27(11). 611–615. 32 indexed citations
20.
Gordon, Nancy, et al.. (2003). Fludarabine and Once-Daily Intravenous Busulfan for Allogeneic Bone Marrow Transplantation for Chediak-Higashi Syndrome. Journal of Pediatric Hematology/Oncology. 25(10). 824–826. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kurosh Rahimi Breakdown of academic impact, for papers by Denis M. Schewe Breakdown of academic impact, for papers by Markus M. Valter Breakdown of academic impact, for papers by Haruko Shima Breakdown of academic impact, for papers by Els Van Nieuwenhuysen Breakdown of academic impact, for papers by Lisa Giulino‐Roth Breakdown of academic impact, for papers by Ellen M. Basu Breakdown of academic impact, for papers by Tomoya Kishimoto Breakdown of academic impact, for papers by Elvis Terci Valera Breakdown of academic impact, for papers by Véronique Laithier
Rankless by CCL
2026